Unlike typical osteoarthritis, where cartilage in joints breaks down, rheumatoid arthritis results from the immune system ...
Australian researchers have discovered that an anti-inflammatory drug already being used to treat rheumatoid arthritis could ...
The Food and Drug Administration has approved a device that uses electrical stimulation to reduce inflammation from rheumatoid arthritis.
Osteoarthritis and Rheumatoid Arthritis sound similar but affect joints differently. Learn their early symptoms and treatment ...
Mar. 24 -- THURSDAY, March 6 (HealthDay News) -- People taking medications for rheumatoid arthritis may also be reducing their risk of heart attack and stroke, a new study suggests. People with ...
"Rheumatoid Arthritis Continues to Challenge Medical Science While Driving Growth in the Global Therapeutics Market"Boston, Oct. 08, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC ...
They’ve been approved for the US market since 2012, but Janus kinase (JAK) inhibitors are still the new kid on the block in terms of rheumatoid arthritis treatment. As such, the real-world evidence on ...
The global rheumatoid arthritis drugs market was valued at US$31.27 billion in 2024 and is projected to reach US$56.62 billion by 2033, ...
NEW YORK (Reuters Health) - To test whether a new drug is an improvement over existing treatments, the ideal clinical trial would compare the medications head to head, but few trials of rheumatoid ...
NEW YORK (Reuters Health) - Three available drugs that belong to the newest class of drugs for treating rheumatoid arthritis -- the tumor necrosis factor (TNF)-alpha blockers -- are equally effective ...
Colorado became the first state in the nation to set a price cap on a specific medication last week, following a unanimous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback